Skip Navigation
Menu
In the Clinic |6 July 2010

Rheumatoid Arthritis

Tom W.J. Huizinga, MD, PhD; Theodore Pincus, MD

FULL TEXT
Editor's Note: This issue of In the Clinic has been updated.
Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease affecting approximately 0.5% of the population. Rheumatoid arthritis is more common in women and may occur at any age, with peak incidence at ages 50 to 60 years. The most prominent feature is symmetrical joint swelling of the feet, hands, and knees, although any joint (and some internal organs) may be affected. Rheumatoid arthritis is a clinical syndrome encompassing several disease subsets, each involving inflammatory cascades that generally lead to joint and organ damage if left untreated. Although laboratory...
FULL TEXT
PDF
Not Available
Citations
Citation

Huizinga TW, Pincus T. Rheumatoid Arthritis. Ann Intern Med. 2010;153:ITC1–1. doi: 10.7326/0003-4819-153-1-201007060-01001

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2010;153(1):ITC1-1.

DOI: 10.7326/0003-4819-153-1-201007060-01001

©
2010 American College of Physicians
0 Citations

Related Articles
Update in Rheumatology: Evidence Published in 2014
Annals of Internal Medicine; 162 (9): W122-W126
Update in Rheumatology: Evidence Published in 2013
Annals of Internal Medicine; 161 (3): 200-204
Triple Therapy Versus Biologic Therapy for Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis
Annals of Internal Medicine; 167 (1): 8-16
Annals for Educators - 19 April 2016
Annals of Internal Medicine; 164 (8): ED8
View MoreView Less

Journal Club
Review: In rheumatoid arthritis, adding rituximab to methotrexate improves clinical outcomes
Annals of Internal Medicine; 162 (12): JC9
In patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms
Annals of Internal Medicine; 168 (4): JC23
Patients with new-onset rheumatoid arthritis had increased risk for ischemic and nonischemic heart failure
Annals of Internal Medicine; 167 (2): JC8
Review: In rheumatoid arthritis, TNF-α inhibitors do not differ from placebo or DMARDs for all-cause mortality
Annals of Internal Medicine; 164 (4): JC20
View MoreView Less

Related Point of Care
Osteoarthritis
Annals of Internal Medicine; 147 (3): ITC8-1
View MoreView Less

Related Topics
Rheumatoid Arthritis
Rheumatology

Rheumatoid Arthritis, Rheumatology.

PubMed Articles
Osseous sarcoidosis: a multicenter case-control study.
Joint Bone Spine 2019.
Azathioprine in combination with methotrexate: a therapeutic alternative in severe and recalcitrant forms of  alopecia  areata?
J Eur Acad Dermatol Venereol 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×